BIOGLUE SURGICAL ADHESIVE UNKNOWN

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,foreig report with the FDA on 2019-03-26 for BIOGLUE SURGICAL ADHESIVE UNKNOWN manufactured by Cryolife, Inc..

Event Text Entries

[139850619] This investigation is currently ongoing. Any additional information will be provided in the follow-up report.
Patient Sequence No: 1, Text Type: N, H10


[139850620] According to the publication hickey, t. B. M. , et al. ? Iatrogenic embolization following cardiac intervention: postmortem analysis of 110 cases*.? Cardiovascular pathology 40 (2019): 12-18. A retrospective clinical pathologic autopsy analysis of 110 people that underwent endovascular procedures between 2010 and 2016 within 90 days of death and followed by hospital autopsy. Case of tissue embolism: "this case (no. 5) involved a (b)(6) woman with a past history of st-segment elevation myocardial infarction, resultant third-degree heart block, permanent pacemaker insertion, and two drug-eluting stents for complete occlusion of the right coronary artery 5 years previously. Due to worsening heart failure, she underwent repair of a left ventricular aneurysm and aortic valve. During the surgery, the left brachiocephalic vein was injured by in situ pacemaker wires and was repaired intraoperatively. A left mca territory infarct was identified day 1 postoperatively. Concurrently, she developed right-sided weakness, and a head ct scan confirmed a recent left mca territory infarct involving the basal ganglia, insula, and left temporal lobe. At autopsy, the left mca contained a tissue embolus confirmed by micro-scopic analysis. The embolic tissue displayed focal granulomatous inflammation to foreign suture-like material that had two appearances: eosinophilic and pale to white. These were suggestive of two different types of sutures. Fragments of eosinophilic material consistent with bioglue surgical adhesive were also identified. Detailed examination of the heart showed a left ventricle aneurysm repair site mural thrombus admixed with bioglue and suture material, the likely source of the left mca embolus. " the patient died 15 days later following the endovascular procedure from the extensive left middle cerebral artery stroke. Cardiac tissue embolized to the left m1 mca artery.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1063481-2019-00013
MDR Report Key8451962
Report SourceCOMPANY REPRESENTATIVE,FOREIG
Date Received2019-03-26
Date of Report2019-06-03
Date Facility Aware2019-03-19
Date Mfgr Received2019-03-19
Date Added to Maude2019-03-26
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactROCHELLE MANEY
Manufacturer Street1655 ROBERTS BLVD
Manufacturer CityKENNESAW GA 30144
Manufacturer CountryUS
Manufacturer Postal30144
Manufacturer Phone7704193355
Manufacturer G1CRYOLIFE, INC.
Manufacturer Street1655 ROBERTS BLVD. NW
Manufacturer CityKENNESAW GA 30144
Manufacturer CountryUS
Manufacturer Postal Code30144
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameBIOGLUE SURGICAL ADHESIVE
Generic NameGLUE,SURGICAL,ARTERIES
Product CodeMUQ
Date Received2019-03-26
Model NumberUNKNOWN
Lot NumberUNKNOWN
Device AvailabilityN
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerCRYOLIFE, INC.
Manufacturer Address1655 ROBERTS BLVD. NW KENNESAW GA 30144 US 30144


Patients

Patient NumberTreatmentOutcomeDate
101. Death 2019-03-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.